We are live on ! Find out more
HSTO

Histogen Inc. Common Stock

Delisted

HSTO was delisted on the 4th of October, 2023.

32 hedge funds and large institutions have $28.1M invested in Histogen Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more capital invested

Capital invested by funds: $25.1M → $28.1M (+$3.02M)

6% more call options, than puts

Call options by funds: $1.43M | Put options by funds: $1.34M

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

11% less funds holding

Funds holding: 3632 (-4)

31% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 13

33% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 9

Holders
32
Holders Change
-4
Holders Change %
-11.11%
% of All Funds
0.85%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
9
Increased
6
Reduced
9
Closed
13
Calls
$1.43M
Puts
$1.34M
Net Calls
+$83K
Net Calls Change
+$165K

HSTO Hedge Fund Activity: Q1 2015 in Review

32 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q1 2015, worth a combined $28.1M — up 12% from $25.1M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of HSTO and 9 opened new positions — a net loss of 4 holders — while 9 trimmed existing stakes and 6 added.

The largest buyer was Axa, adding an estimated $1.91M. The largest seller was Millennium Management, exiting entirely with an estimated $758K sold.

  • 32 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q1 2015, down from 36 in Q4 2014.
  • Funds reported $28.1M of Histogen Inc. Common Stock stock for Q1 2015, up 12% quarter-over-quarter.
  • 9 funds opened new Histogen Inc. Common Stock positions in Q1 2015 and 13 closed out, a net change of -4 holders.
  • The largest Histogen Inc. Common Stock buyer in Q1 2015 was Axa, an estimated $1.91M added.
  • The largest Histogen Inc. Common Stock seller in Q1 2015 was Millennium Management, an estimated $758K sold.

Based on aggregated 13F filings for Q1 2015.